Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Narayanan

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
BMJ Open|January 14, 2025
Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancerUma Anne Mukherjee, Helen Hockings, Nicholas Counsell, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Lipid composition differentiates ferroptosis sensitivity between <i>in vitro</i> and <i>in vivo</i> systemsVivian S Park, Lauren E Pope, Justin Ingram, et al.
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
Cell Death & Disease|October 10, 2023
Calbindin 2-specific deletion of arginase 2 preserves visual function after optic nerve crushSyed A H Zaidi, Zhimin Xu, Tahira Lemtalsi, et al.
Cell Death & Disease|August 29, 2022
Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repairAbdelrahman Y Fouda, Zhimin Xu, Jutamas Suwanpradid, et al.
Cell Death & Disease|September 27, 2018
Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responsesAbdelrahman Y Fouda, Zhimin Xu, Esraa Shosha, et al.
Cancer Research|September 5, 2025
Lipid Composition Alters Ferroptosis SensitivityVivian S Park, Lauren E Pope, Justin P Ingram, et al.
Placenta|August 27, 2023
Use of super resolution reconstruction MRI for surgical planning in Placenta accreta spectrum disorder: Case seriesNada Mufti, Joanna Chappell, Patrick O'Brien, et al.
Scientific Reports|November 4, 2025
A feasibility study of whole genome germline testing as an adjunct screening tool in a UK general private practiceAnn-Britt Jones, Gabriella Pichert, Lucy Side, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
BMJ Open|January 14, 2025
Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancerUma Anne Mukherjee, Helen Hockings, Nicholas Counsell, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Lipid composition differentiates ferroptosis sensitivity between <i>in vitro</i> and <i>in vivo</i> systemsVivian S Park, Lauren E Pope, Justin Ingram, et al.
JAMA Oncology|February 6, 2025
Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical TrialRebecca Kristeleit, Michael-John Devlin, Andrew Clamp, et al.
Cell Death & Disease|October 10, 2023
Calbindin 2-specific deletion of arginase 2 preserves visual function after optic nerve crushSyed A H Zaidi, Zhimin Xu, Tahira Lemtalsi, et al.
Cell Death & Disease|August 29, 2022
Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repairAbdelrahman Y Fouda, Zhimin Xu, Jutamas Suwanpradid, et al.
Cell Death & Disease|September 27, 2018
Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responsesAbdelrahman Y Fouda, Zhimin Xu, Esraa Shosha, et al.
Cancer Research|September 5, 2025
Lipid Composition Alters Ferroptosis SensitivityVivian S Park, Lauren E Pope, Justin P Ingram, et al.
Placenta|August 27, 2023
Use of super resolution reconstruction MRI for surgical planning in Placenta accreta spectrum disorder: Case seriesNada Mufti, Joanna Chappell, Patrick O'Brien, et al.
Scientific Reports|November 4, 2025
A feasibility study of whole genome germline testing as an adjunct screening tool in a UK general private practiceAnn-Britt Jones, Gabriella Pichert, Lucy Side, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
Pageof 10